CD4 and neoplasm: Preliminary analysis showed that of the patients who received ADT followed by docetaxel and then PROSTVAC, 31%, 50%, and 50% had CD4/CD8 responses to tumor antigens PSA, MUC-1, and brachyury, respectively.